Search - tctmd.com

Displaying 61 - 80 of 155

Sort: Relevancy | Date

News Daily News

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

Shelley Wood

December 15, 2020

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Featured Fellow

Marwan Saad, MD, PhD

Yael L. Maxwell

September 08, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Daily News

Super-Responders in COAPT: Improving MR and QoL Is Key

Shelley Wood

August 24, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Conference News ACC 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

Todd Neale

March 29, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Daily News

Year in Review: Digital Health and A-fib Ablation Top 2019 Heart Rhythm News

Todd Neale

December 19, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

Advertisement

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Marwan Saad, MD, PhD

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

Super-Responders in COAPT: Improving MR and QoL Is Key

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Newer TAVR Devices Reassure in Failed Surgical Valves

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Year in Review: Digital Health and A-fib Ablation Top 2019 Heart Rhythm News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content